Healthcare -
Drug Manufacturers - General - NASDAQ - US
$ 141.61
0.79 %
$ 20.7 B
Market Cap
12.67
P/E
BIIB - REVENUE
Revenue BIIB - Biogen Inc.
9.68 B
LAST VALUE
-2.48%
2 YEAR CAGR
-7.62%
5 YEAR CAGR
-0.03%
10 YEAR CAGR